Prime Medicine

Developing precision gene editing therapies to treat genetic diseases.

BiotechnologyPharmaceuticals primemedicine.com ↗

Company facts

Founded
2019
Employees
214
Headquarters
United States
Type
Public
Listed
NASDAQ: PRME
Subsidiaries
Prime Medicine Massachusetts Securities Corp.